Expert said that manufacturing the T cells with a tyrosine kinase inhibitor may allow more patients to get allogeneic stem cell transplant, the current best means of long-term cure.
/PRNewswire/ The T-Cell Lymphoma Market size is expected to grow by USD 768.07 million during 2021-2026, at a CAGR of 8.21% during the forecast period,.